Ubiquitin and SUMO conjugation as biomarkers of Acute Myeloid Leukemias response to chemotherapies
P. Gatel, F. Brockly, C. Reynes, M. Pastore, Y. Hicheri, G. Cartron, M. Piechaczyk, G. Bossis
This paper identifies ubiquitin and SUMO conjugation biomarkers to predict AML response to chemotherapy and develops an assay to measure them.
bioRxiv · Oct 31, 2019Cancer Biology